About Training
Our team of highly credentialed experts will teach physicians how to practice cell therapy safely and effectively. Upon completion of training, certificates and ongoing one-on-one support will be provided.
Who We Are
We are determined to help advance the field of regenerative medicine through high quality education.
Cell Therapy
Basing treatments on sound scientific evidence is crucial, and at AAICT, we help physicians stay abreast with the thriving scene of stem cell research from around the globe.
Organization
A panel of highly regarded physicians who are experts in various and diverse aspects of stem cell therapy.
Training for Providers
American Academy of Integrative Cell Therapy (AAICT) provides training courses and certifications for physicians and other healthcare professionals.
Next Certification: July 19th-20th 2025
Board Members
Latest Tips & Articles
Chinese doctor claims breakthrough in coronavirus pandemic with stem cell injections – 100% success rate after treating nine patients
A Chinese doctor who runs a lab in Wuhan - ground zero of the coronavirus pandemic - claims he could save thousands of lives after making a breakthrough in the treatment of the deadly pathogen, DailyMailTV can reveal. Dr. Dongcheng Wu, an expert in stem cell therapy,...
Coronavirus: critically ill Chinese patient saved by stem cell therapy, study says
A 65-year-old Chinese woman who fell seriously ill after being infected with the coronavirus made a startling recovery after being given stem cell therapy, according to a new study by Chinese scientists. The patient had been fighting for her life in the intensive care...
Struggling With Menopause? New Stem Cell Treatments Can Help
After stem cells from bone marrow were injected into the ovaries of 33 women, the scientific community is hopeful that the new treatment may be able to help reverse the effects
Parkinson’s symptoms reversed in monkeys by groundbreaking new treatment
A treatment that could reverse some of the main symptoms of Parkinson’s disease – potentially enabling patients to recover enough control of their movements to play tennis – is set to be trialled in humans for the first time.
